期刊论文详细信息
Lipids in Health and Disease
Effect of dietary resveratrol on the metabolic profile of nutrients in obese OLETF rats
Teruyoshi Yanagita2  Shunichi Kai1  Tomoyuki Jinnouchi1  Koji Nagao1 
[1] Department of Applied Biochemistry and Food Science, Saga University, Saga, 840-8502, Japan;Department of Health and Nutrition Sciences, Nishikyushu University, Kanzaki, 842-8585, Japan
关键词: OLETF rat;    Obesity;    Metabolic profile;    Respiratory gas analysis;    Resveratrol;   
Others  :  1160095
DOI  :  10.1186/1476-511X-12-8
 received in 2012-12-23, accepted in 2013-01-31,  发布年份 2013
PDF
【 摘 要 】

Background

Resveratrol (trans-3,4,5-trihydroxystilbene) is a naturally occurring phytoalexin produced by plants in response to various stresses. Several studies have shown that resveratrol is present in significant amounts in a variety of human diets, including wines, grapes, berries, and peanuts, and it possesses several beneficial health properties, such as atheroprotective, anti-obesity, anti-cancer, anti-inflammatory and antioxidant activities. In this study, we evaluated the effect of resveratrol on the pathogenesis of obesity and the metabolic profile of nutrients in non-high fat-fed obese OLETF rats.

Results

Although lipid parameters in the serum and liver were not changed, the accumulation of abdominal white adipose tissues was markedly prevented in resveratrol diet-fed OLETF rats after 4 weeks of feeding. The results of the respiratory gas analysis indicated that dietary resveratrol induced the partial enhancement of fat metabolism and sparing actions for carbohydrate and protein at 1 week and 3 weeks of feeding in OLETF rats. Additionally, the adipose mRNA level of carnitine palmitoyltransferase in the resveratrol diet-fed OLETF rats was higher than the control rats after 4 weeks of feeding.

Conclusion

Our study demonstrated that dietary resveratrol can prevent obesity through a change in the metabolic profile of nutrients in obese OLETF rats.

【 授权许可】

   
2013 Nagao et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150410093658191.pdf 434KB PDF download
Figure 4. 34KB Image download
Figure 3. 30KB Image download
Figure 2. 65KB Image download
Figure 1. 31KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】
  • [1]Kissebah AH, Krakower GR: Regional adiposity and morbidity. Physiol Rev 1994, 74:761-811.
  • [2]Must A, Spadano J, Coakley EH, Field AE, Colditz G, Detz WH: The disease burden associated with overweight and obesity. JAMA 1999, 282:1523-1529.
  • [3]Adler A: Obesity and target organ damage: diabetes. Int J Obes Relat Metab Disord 2002, 26:S11-S14.
  • [4]Fiegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among U.S. adults 1999–2000. AMA 2002, 288:1723-1727.
  • [5]Pi-Sunyer FX: The medical risks of obesity. Obes Surg 2002, 12:S6-S11.
  • [6]Manach C, Mazur A, Scalbert A: Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol 2005, 16:77-84.
  • [7]Nagao K, Inoue N, Inafuku M, Shirouchi B, Morooka T, Nomura S, Nagamori N, Yanagita T: Mukitake mushroom (Panellus serotinus) alleviates nonalcoholic fatty liver disease through the suppression of monocyte chemoattractant protein-1 production in db/db mice. J Nutr Biochem 2010, 21:418-423.
  • [8]Inafuku M, Nagao K, Nomura S, Shirouchi B, Inoue N, Nagamori N, Nakayama H, Toda T, Yanagita T: Protective effects of fractional extracts from Panellus serotinus on nonalcoholic fatty liver disease in obese, diabetic db/db mice. Br J Nutr 2012, 107:639-646.
  • [9]Nagao K, Yamano N, Shirouchi B, Inoue N, Murakami S, Sasaki T, Yanagita T: Effects of citrus auraptene (7-geranyloxycoumarin) on hepatic lipid metabolism in vitro and in vivo. J Agric Food Chem 2010, 58:9028-9032.
  • [10]Tsuruta Y, Nagao K, Kai S, Yoshimura T, Tsuge K, Koganemaru K, Yanagita T: Polyphenolic extract of lotus root (edible rhizome of Nelumbo nucifera) alleviates hepatic steatosis in obese diabetic db/db mice. Lipids Health Dis 2011, 10:202. BioMed Central Full Text
  • [11]Huang X, Zhu HL: Resveratrol and its analogues: promising antitumor agents. Anticancer Agents Med Chem 2011, 11:479-490.
  • [12]Do GM, Jung UJ, Park HJ, Kwon EY, Jeon SM, McGregor RA, Choi MS: Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice. Mol Nutr Food Res 2012, 56:1282-1291.
  • [13]Gómez-Zorita S, Fernández-Quintela A, Macarulla MT, Aguirre L, Hijona E, Bujanda L, Milagro F, Martínez JA, Portillo MP: Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress. Cardiovasc Br J Nutr 2012, 107:202-210.
  • [14]Kim S, Jin Y, Choi Y, Park T: Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochem Pharmacol 2011, 81:1343-1351.
  • [15]Alberdin G, Rodríguez VM, Miranda J, Macarulla MT, Arias N, Andrés-Lacueva C, Portillo MP: Changes in white adipose tissue metabolism induced by resveratrol in rats. Nutr Metab 2011, 8:29. BioMed Central Full Text
  • [16]Nagao K, Inoue N, Wang YM, Hirata J, Shimada Y, Nagao T, Matsui T, Yanagita T: The 10trans,12cis isomer of conjugated linoleic acid suppresses the development of hypertension in Otsuka Long-Evans Tokushima fatty rats. Biochem Biophys Res Commun 2003, 306:134-138.
  • [17]Arao K, Wang YM, Inoue N, Hirata J, Cha JY, Nagao K, Yanagita T: Dietary effect of pomegranate seed oil rich in 9cis,11trans,13cis conjugated linolenic acid on lipid metabolism in obese, hyperlipidemic OLETF Rats. Lipids Health Dis 2004, 3:24. BioMed Central Full Text
  • [18]Wang YM, Nagao K, Inoue N, Ujino Y, Shimada Y, Nagao T, Iwata T, Kamegai T, Yamauchi-Sato Y, Yanagita T: Isomer-specific anti-obese and hypolipidemic properties of conjugated linoleic acid in obese OLETF rats. Biosci Biotechnol Biochem 2006, 70:355-362.
  • [19]Shirouchi B, Nagao K, Inoue N, Ohkubo T, Hibino H, Yanagita T: Effect of dietary omega 3 phosphatidylcholine on obesity-related disorders in obese Otsuka Long-Evans Tokushima Fatty rats. J Agric Food Chem 2007, 55:7170-7176.
  • [20]Inoue N, Nagao K, Sakata K, Yamano N, Gunawardena ERP, Han SY, Matsui T, Nakamori T, Furuta H, Takamatsu K, Yanagita T: Screening of soy protein-derived hypotriglyceridemic di-peptides in vitro and in vivo. Lipids Health Dis 2011, 10:85. BioMed Central Full Text
  • [21]Inoue N, Nagao N, Nomura S, Shirouchi B, Inafuku M, Hirabaru H, Nakahara N, Nishizono S, Tanaka T, Yanagita T: Effect of Vaccinium ashei reade leaf extracts on lipid metabolism in obese OLETF rats. Biosci Biotechnol Biochem 2011, 75:2304-2308.
  • [22]Shirouchi B, Nagao K, Inoue N, Furuya K, Koga S, Matsumoto H, Yanagita T: Dietary phosphatidylinositol prevents the development of nonalcoholic fatty liver disease in Zucker (fa/fa) rats. J Agric Food Chem 2008, 56:2375-2379.
  • [23]Lo S, Russell JC, Taylor AW: Determination of glycogen in small tissue samples. J Appl Physiol 1970, 28:234-236.
  • [24]Nagao K, Wang YM, Inoue N, Han SY, Buang Y, Noda T, Kouda N, Okamatsu H, Yanagita T: The 10trans,12cis isomer of conjugated linoleic acid promotes energy metabolism in OLETF rats. Nutrition 2003, 19:652-656.
  • [25]Ikeda I, Konno R, Shimizu T, Ide T, Takahashi N, Kawada T, Nagao K, Inoue N, Yanagita T, Hamada T, Morinaga Y, Tomoyori H, Imaizumi K, Suzuki K: Campest-5-en-3-one, an oxidized derivative of campesterol, activates PPARα, promotes energy consumption and reduces visceral fat deposition in rats. Biochim Biophys Acta 2006, 1760:800-807.
  • [26]Nagao K, Yanagita T: Bioactive lipids in metabolic syndrome. Prog Lipid Res 2008, 47:127-146.
  • [27]Nagao K, Yanagita T: Medium-chain fatty acids: Functional lipids for the prevention and treatment of the metabolic syndrome. Pharm Res 2010, 61:208-212.
  • [28]Yeo WK, Carey AL, Burke L, Spriet LL, Hawley JA: Fat adaptation in well-trained athletes: effects on cell metabolism. Physiol Nutr Metab 2011, 36:12-22.
  • [29]Yeo WK, Lessard SJ, Chen ZP, Garnham AP, Burke LM, Rivas DA, Kemp BE, Hawley JA: Fat adaptation followed by carbohydrate restoration increases AMPK activity in skeletal muscle from trained humans. J Appl Physiol 2008, 105:1519-1526.
  • [30]Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, Andreelli F: Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J Physiol 2006, 574:41-53.
  • [31]Cheng G, Zhang X, Gao D, Jiang X, Dong W: Resveratrol inhibits MMP-9 expression by up-regulating PPAR α expression in an oxygen glucose deprivation-exposed neuron model. Neurosci Lett 2009, 451:105-108.
  • [32]Takahashi S, Nakashima Y: Repeated and long-term treatment with physiological concentrations of resveratrol promotes NO production in vascular endothelial cells. Br J Nutr 2012, 107:774-780.
  文献评价指标  
  下载次数:78次 浏览次数:22次